Document Detail

The impact of the United Nations Convention on Biological Diversity on natural products research.
MedLine Citation:
PMID:  23037777     Owner:  NLM     Status:  Publisher    
Covering: 1955 to 2012The discovery and development of novel, biologically active agents from natural sources, whether they be drugs, agrochemicals or other bioactive entities, involve a high level of interdisciplinary as well as international collaboration. Such collaboration, particularly at the international level, requires the careful negotiation of collaborative agreements protecting the rights of all parties, with special attention being paid to the rights of host (source) country governments, communities and scientific organizations. While many biodiversity-rich source countries currently might not have the necessary resources for in-country drug discovery and advanced development, they provide valuable opportunities for collaboration in this endeavor with research organizations from more high-income nations. This chapter discusses the experiences of the US National Cancer Institute and the US government-sponsored International Cooperative Biodiversity Groups program in the establishment of international agreements in the context of the Convention of Biological Diversity's objectives of promoting fair and equitable collaboration with multiple parties in many countries, and includes some specific lessons of value in developing such collaborations.
Gordon M Cragg; Flora Katz; David J Newman; Joshua Rosenthal
Related Documents :
22120457 - This month in ajp.
22039407 - Can research assessments themselves cause bias in behaviour change trials? a systematic...
11571047 - Evidence that helping at the nest does not result in territory inheritance in the seych...
24891467 - The impact of the fogarty international clinical scholars and fellows program extends b...
23640187 - The intriguing future of pharmacoepidemiology.
17510667 - Can we develop ethically universal embryonic stem-cell lines?
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-5
Journal Detail:
Title:  Natural product reports     Volume:  -     ISSN:  1460-4752     ISO Abbreviation:  Nat Prod Rep     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8502408     Medline TA:  Nat Prod Rep     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Natural Products Branch, National Cancer Institute-Frederick, P. O. Box B, Frederick, Maryland 21702-1201, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Hopf bifurcation stability in Hopfield neural networks.
Next Document:  Sandwich-like Cu(1.94)S-ZnS-Cu(1.94)S nanoheterostructure: structure, formation mechanism and locali...